Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

PRAMULIN THERAPEUTICS : revenue, balance sheet and financial ratios

PRAMULIN THERAPEUTICS is a French company founded 2 years ago, specialized in the sector Fabrication de préparations pharmaceutiques. Based in LYON (69003), this company of category PME has financial data available below. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PRAMULIN THERAPEUTICS (SIREN 982727943)
Indicator 2023
Revenue N/C
Net income 0 €
EBITDA N/C
Net margin N/C

Revenue and income statement

In 2023, PRAMULIN THERAPEUTICS records a net loss of 0 €. This deficit will reduce equity on the balance sheet.

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

100.0%

Solvency indicators evolution
PRAMULIN THERAPEUTICS

Sector positioning

Debt ratio
0.0 2023
2023
Q1: 0.0
Med: 2.28
Q3: 51.98
Excellent

In 2023, the debt ratio of PRAMULIN THERAPEUTICS (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
100.0% 2023
2023
Q1: 25.54%
Med: 52.2%
Q3: 68.87%
Excellent

In 2023, the financial autonomy of PRAMULIN THERAPEUTICS (100.0%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Positioning of PRAMULIN THERAPEUTICS in its sector

Comparison with sector Fabrication de préparations pharmaceutiques

Similar companies (Fabrication de préparations pharmaceutiques)

Compare PRAMULIN THERAPEUTICS with other companies in the same sector:

Frequently asked questions about PRAMULIN THERAPEUTICS

What is the revenue of PRAMULIN THERAPEUTICS ?

The revenue of PRAMULIN THERAPEUTICS is not publicly disclosed (confidential accounts filed with INPI).

Is PRAMULIN THERAPEUTICS profitable?

Profitability information is not publicly available.

Where is the headquarters of PRAMULIN THERAPEUTICS ?

The headquarters of PRAMULIN THERAPEUTICS is located in LYON (69003), in the department Rhone.

Where to find the tax return of PRAMULIN THERAPEUTICS ?

The tax return of PRAMULIN THERAPEUTICS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PRAMULIN THERAPEUTICS operate?

PRAMULIN THERAPEUTICS operates in the sector Fabrication de préparations pharmaceutiques (NAF code 21.20Z). See the 'Sector positioning' section above to compare the company with its competitors.